For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -97℃ for several months.
英文名:
Lapatinib
库存:
详询
供应商:
详询
CAS号:
231277-92-2
规格:
5mg/10mg/25mg/50mg/1ml/10mM
规格:
5mg
产品价格:
¥268.0
规格:
10mg
产品价格:
¥398.0
规格:
25mg
产品价格:
¥718.0
规格:
50mg
产品价格:
¥1088.0
规格:
1ml/10mM
产品价格:
¥458.0
ID:T0078
PURITY:0.985
Formula:C29H26ClFN4O4S
MolWt:581.06
Appearance:淡黄色粉末
Solubility:G4Soluble in DMSO
Bioactivity:Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.